Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Bayer is pressing ... given alongside aspirin plus a P2Y12 inhibitor – at one year. Once again, there was no significant observed increase in bleeding with asundexian at any dose or compared ...

As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...

Description The goal of the trial was to evaluate treatment with famotidine compared with placebo among patients taking low-dose aspirin. Hypothesis Famotidine would be more effective in ...

Bayer (BAYZF) stock in focus as the company inks a licensing deal with Puhe BioPharma to develop a cancer candidate targeting ...

Studies of people with cancer have previously observed that those taking daily low-dose aspirin have a reduction in the spread of some cancers, such as breast, bowel, and prostate cancers ...

Prior studies showed aspirin can reduce incidence of colorectal cancer. One study presented at this year’s ASCO Gastrointestinal Cancers Symposium showed low-dose aspirin significantly reduced ...

Paracetamol, aspirin and ibuprofen are among the most widely used. While they are all effective for pain relief, they each ...

Studies of people with cancer have previously observed that those taking daily low-dose aspirin have a reduction in the spread of some cancers, such as breast, bowel, and prostate cancers ...

In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge ...

Aspirin inhibits the production of TXA2 by platelets, which is why people sometimes take it at low doses to reduce the ... and particularly in those taking a daily dose, it may cause bleeding ...